Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kevin J. Curran"'
Autor:
Audrey Mauguen, Brian C. Shaffer, Ichelle van Roessel, Richard J. O'Reilly, Michael Scordo, Nancy A. Kernan, Christina Cho, Andrew L. Kung, Andromachi Scaradavou, Maria Cancio, Sergio Giralt, Miguel-Angel Perales, Barbara Spitzer, Kevin J. Curran, Madhavi Lakkaraja, Esperanza B. Papadopoulos, Elizabeth Klein, Sean M. Devlin, Farid Boulad, Susan E. Prockop, Ann A. Jakubowski, Gunjan L. Shah, Roni Tamari, Jaap Jan Boelens, Scott Avecilla, Josel D. Ruiz
Publikováno v:
Blood advances. 6(3)
Traditional weight-based dosing results in variable rabbit antithymocyte globulin (rATG) clearance that can delay CD4+ T-cell immune reconstitution (CD4+ IR) leading to higher mortality. In a retrospective pharmacokinetic/pharmacodynamic (PK/PD) anal
Autor:
Andromachi Scaradavou, Maria Cancio, Celina L. Szanto, Mirjam E. Belderbos, Elizabeth Klein, Wouter J.W. Kollen, Farid Boulad, Nancy A. Kernan, Dorine Bresters, Marc Bierings, Stefan Nierkens, Kevin J. Curran, Barbara Spitzer, Coco de Koning, Jurgen Langenhorst, Jaap Jan Boelens, Birgitta Versluijs, Caroline A. Lindemans, Susan E. Prockop, Alwin D. R. Huitema, Ichelle van Roessel, Richard J. O'Reilly
Publikováno v:
Blood
Acute graft-versus-host-Disease (aGVHD) is a major cause of morbidity and mortality after allogeneic hematopoietic cell transplantation (HCT). We previously showed that early CD4+ T-cell immune reconstitution (IR; CD4+ IR) predicts survival after HCT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5555c041f4a96722046831f6ef4a6558
https://europepmc.org/articles/PMC7986048/
https://europepmc.org/articles/PMC7986048/
Autor:
Andromachi Scaradavou, Meghan A. Higman, Barbara Spitzer, Jennifer Allen, Nicholas D. Yeager, Audrey Mauguen, Nancy A. Kernan, Elliot Stieglitz, Maria Cancio, Farid Boulad, Niketa C. Shah, Kevin J Curran, Vanessa A Fabrizio, Susan E. Prockop, Steven P. Margossian, Richard J. O'Reilly, Renier J. Brentjens, Jaap Jan Boelens
Publikováno v:
Bone marrow transplantation, vol 55, iss 11
Bone marrow transplantation
Bone marrow transplantation
To define the tolerability and outcome of allogeneic hematopoietic stem cell transplant (allo-HSCT) following CAR T-cell therapy, we retrospectively reviewed pediatric/young adult patients with relapsed/refractory B-ALL who underwent this treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32cde197e69454cd2acee0da2cb995dc
https://escholarship.org/uc/item/9sv0d1wj
https://escholarship.org/uc/item/9sv0d1wj
Autor:
Mercedes Castiel, Richard J. O'Reilly, Nicole Zakak, Praveen Anur, Andromachi Scaradavou, Bhuvanesh Singh, Charles A. Sklar, Julia Kearney, Kevin C. Oeffinger, Danielle Novetsky Friedman, Rachel Kobos, Susan E. Prockop, Farid Boulad, Julianne Ruggiero, Nancy A. Kernan, Kevin J. Curran
Publikováno v:
Bone marrow transplantation
Hematopoietic stem cell transplantation (HSCT) is curative for hematological manifestations of Fanconi anemia (FA). We performed a retrospective analysis of 22 patients with FA and aplastic anemia, myelodysplastic syndrome or acute myelogenous leukem